BTIS
ATRS

BB&T Investment Services’s Antares Pharma, Inc. ATRS Stock Holding History

BB&T Investment Services’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$6K Hold
2,780
– – ﹤0.01% 1080
2017
Q3 		$9K Hold
2,780
– – ﹤0.01% 868
2017
Q2 		$9K Hold
2,780
– – ﹤0.01% 813
2017
Q1 		$8K Hold
2,780
– – ﹤0.01% 757
2016
Q4 		$6K Buy
+2,780
New +$5.29K ﹤0.01% 584

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BB&T Investment Services's ATRS Position: Q4 2017 in Review

BB&T Investment Services held its Antares Pharma, Inc. (ATRS) position steady in Q4 2017 at 2,780 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1080.

BB&T Investment Services first reported a position in ATRS in Q4 2016 and has held it in 5 quarters since. The position peaked at $9K in Q3 2017. 110 funds tracked by Wall St. Rank hold ATRS as of Q4 2017.

  • BB&T Investment Services held 2,780 shares of Antares Pharma, Inc. worth $6K as of Q4 2017.
  • BB&T Investment Services left its Antares Pharma, Inc. share count unchanged in Q4 2017.
  • Antares Pharma, Inc. made up ﹤0.01% of BB&T Investment Services's portfolio in Q4 2017, its #1080 holding.
  • BB&T Investment Services first reported a position in Antares Pharma, Inc. in Q4 2016 and has held it in 5 quarters since.
  • BB&T Investment Services's Antares Pharma, Inc. position peaked at $9K in Q3 2017.
  • 110 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.